All lobbying filings

Mr. Brian Kelly

Mr. Brian Kelly filed a Q4 report for Takeda Pharmaceutical Company on January 20, 2026, reporting $10,000 in lobbying income.

Lobbying for Takeda Pharmaceutical Company · Pharmaceuticals

As filed: MR. BRIAN KELLY for TAKEDA PHARMACEUTICAL COMPANY.

All filings by Mr. Brian Kelly · Everything Takeda Pharmaceutical Company has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Income

$10,000

What the client paid this registrant for the period.

Client based in

Massachusetts

Official filing document

Government bodies contacted 5

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 4

Pharmacy

Trade and tariffs

Tariff (miscellaneous tariff bills)

Government tariffs on drug imporatation.

Trade (domestic/foreign)

Trade/Tariffs on drug pricing and importation

Taxation/Internal Revenue Code

tax issues related to drugs and pricing

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.